Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PIPERACILLIN AND TAZOBACTAM FOR INJECTION STERIMAX INC Actual shortage 0.375G 3.000G Updated Report 2024-06-20 227019
PIPERACILLIN AND TAZOBACTAM FOR INJECTION STERIMAX INC Actual shortage 0.5G 4.0G Updated Report 2024-06-20 227022
TEVA-TOPILENE TEVA CANADA LIMITED Actual shortage 0.05% Updated Report 2024-06-20 220989
TEVA-TOPISONE TEVA CANADA LIMITED Actual shortage 0.05% Updated Report 2024-06-20 220992
TEVA-CLOBETASOL TEVA CANADA LIMITED Actual shortage 0.05% Updated Report 2024-06-20 215704
TEVA-TOPILENE TEVA CANADA LIMITED Actual shortage 0.05% Updated Report 2024-06-20 218949
TEVA-IPRATROPIUM STERINEBS TEVA CANADA LIMITED Actual shortage 250MCG Updated Report 2024-06-20 198292
TEVA-SALBUTAMOL STERINEBS P.F. TEVA CANADA LIMITED Actual shortage 2MG Updated Report 2024-06-20 220261
TEVA-SALBUTAMOL STERINEBS P.F. TEVA CANADA LIMITED Actual shortage 1MG Updated Report 2024-06-20 215707
TEVA-EVEROLIMUS TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-06-20 227509

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-06-20 223420
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Reversed 6.3MG Updated Report 2024-06-19 228169
INVOKAMET JANSSEN INC To be discontinued 500MG 150MG New Report 2024-06-18 230850
NAPROXEN - 500 PRO DOC LIMITEE To be discontinued 500MG New Report 2024-06-17 230716
NAPROXEN-375 PRO DOC LIMITEE To be discontinued 375MG New Report 2024-06-17 230710